2022 American Transplant Congress
Efficacy and Safety of Angiotensin II Compared to Catecholamine Vasopressors as a First-Line Vasopressor for Perioperative Hypotension in Kidney Transplant Recipients
*Purpose: Perioperative use of catecholamine vasopressors (CV) in kidney transplantation (KT) have been associated with negative renal outcomes and the development of arrhythmias. A more…2022 American Transplant Congress
Comparison of Statin-Associated Adverse Events Across Different Types of Statins in Kidney Transplant Recipients
*Purpose: Statins are the third most prescribed drug class in kidney transplant (KT) recipients. Statin’s safety profile in KT recipients remains unclear, although these individuals…2022 American Transplant Congress
Donor Terminal Creatinine – Does It Matter?
*Purpose: When assessing deceased donor kidneys, the transplantation team studies several donor variables including creatinine. A creatinine that is elevated immediately prior to procurement can…2022 American Transplant Congress
A New Chapter In An Evolving Pandemic: Successful Pediatric Liver Transplantation With Covid+ Donors
*Purpose: We report the first two pediatric liver transplants utilizing allografts from COVID+ donors, infected at time of organ procurement, demonstrating a pivotal step toward…2022 American Transplant Congress
Identical Kidneys Are Discarded at Higher Rates When Labeled as High KDPI
University of Washington, Seattle, WA
*Purpose: The kidney donor risk index (KDRI) and percentile conversion kidney donor profile index (KDPI) were introduced with the Kidney Allocation System (KAS) to provide…2022 American Transplant Congress
Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients
*Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…2022 American Transplant Congress
Transplant Combined with Neoadjuvant Therapy Improves Survival for Patients with Liver-Limited, Locally Advanced Intrahepatic Cholangiocarcinoma: A SEER Database Analysis
*Purpose: Preliminary single-center data suggest multimodal therapy may improve outcomes for patients with intrahepatic cholangiocarcinoma (iCCA) undergoing liver transplant (LT), particularly in the setting of…2022 American Transplant Congress
Post-Kidney Transplant Valacyclovir or Valganciclovir for EBV Prophylaxis: A Randomized Controlled Trial
*Purpose: EBV viremia post-kidney transplant (KTx) has no proven prophylaxis.*Methods: In this randomized, open-label trial [NCT01329185], adult and pediatric recipients were randomly assigned (1:1) to…2022 American Transplant Congress
Individual and Community-Level Social Determinants of Health in Liver Transplant
*Purpose: To investigate the individual and census-level social determinants of health on liver transplant listing.*Methods: Retrospective review of patients referred to the University of California…2022 American Transplant Congress
Novel Phenotype of Intragraft Endothelial Cells That Modulates CD4+ T Effector-Mediated Rejection
Boston Children's Hospital, Boston, MA
*Purpose: Previous studies have suggested that early adoptive transfer of Teff into Rag KO mice bearing cardiac transplants results in acute rejection. However, if transfer…
- « Previous Page
- 1
- …
- 183
- 184
- 185
- 186
- 187
- …
- 190
- Next Page »